The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fed Versus 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy Adult Male Subjects
NCT06872866
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The objective of this phase 1 study is to evaluate the food effect of 100 mg Hezkue Turbo® (ASP-001.1, sildenafil) under fed versus 100 mg of Hezkue Turbo® (ASP-001.1, sildenafil) under fasted conditions in healthy adult male subjects
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Erectile Dysfunction
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1
- Ages
- 20 to 70 years
- Sex
- Male
- Healthy volunteers
- Accepted
- Sponsor
- Aspargo Labs, Inc
- Last updated on ClinicalTrials.gov
- November 19, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New York · 1
- Aspargo Labs · New York, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.